Welcome to the Podiatry Arena forums

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members, upload content, view attachments, receive a weekly email update of new discussions, access other special features. Registered users do not get displayed the advertisements in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

  1. Everything that you are ever going to want to know about running shoes: Running Shoes Boot Camp Online, for taking it to the next level? See here for more.
    Dismiss Notice
  2. Have you considered the Critical Thinking and Skeptical Boot Camp, for taking it to the next level? See here for more.
    Dismiss Notice
  3. Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
    Dismiss Notice
Dismiss Notice
Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
Dismiss Notice
Have you liked us on Facebook to get our updates? Please do. Click here for our Facebook page.
Dismiss Notice
Do you get the weekly newsletter that Podiatry Arena sends out to update everybody? If not, click here to organise this.

Ben Goldacre : Unreported instances of negative data

Discussion in 'Break Room' started by Cameron, Nov 23, 2014.

  1. Cameron

    Cameron Well-Known Member


    Members do not see these Ads. Sign Up.
    netizens

    From Ben Goldacre
    https://www.youtube.com/watch?v=RKmxL8VYy0M

    When a new drug gets tested, the results of the trials should be published for the rest of the medical world, except much of the time, negative or inconclusive findings go unreported, leaving doctors and researchers in the dark. In this impassioned talk, Ben Goldacre explains why these unreported instances of negative data are especially misleading and dangerous.

    Perhaps there is a lesson here for podiatry.

    What say you?


    toeslayer
     
  2. citychiropody

    citychiropody Member

    read most of his books ...very scary ! makes me not believe anything I read in clinical trial data- particularly marketing claims data !
     
Loading...

Share This Page